Targeted & Immunotherapy – Drug Information( With Evidence Of Use) ABEMACICLIB ACALABRUTINIB ADO TRASTUZUMAB EMTANSINE AFATINIB ALDESLEUKIN ALEMTUZUMAB ALPELISIB ASCIMINIB ATEZOLIZUMAB AVAPRITINIB AVELUMAB AXITINIB BELZUTIFAN BEVACIZUMAB BLINATUMOMAB BOSUTINIB BRENTUXIMAB BRIGATINIB CABOZANTINIB CAPIVASERTIB CAPMATINIB CEMIPLIMAB RWLC CERITINIB CETUXIMAB CRIZOTINIB DABRAFENIB DACOMITINIB DARATUMUMAB DARLUTAMIDE DASATINIB DOSTARLIMA GXLY DURVALUMAB ENCORAFENIB EFLORNITHINE ENFORTUMAB VEDOTIN-EJFV ENTRECTINIB ERLOTINIB FAM-TRASTUZUMAB-DERUXTECAN-NXKI FRUQUINTINIB FUTIBATINIB GEFTINIB IBRITUMOMAB IMATINIB IVOSIDENIB LAPATINIB LAROTRECTINIB LENVATINIB LORLATINIB MARGETUXIMAB-CMKB MIRVETUXIMAB SORAVTANSINE-GYNX NIROGACESTAT NILOTINIB NIRAPARIB NIVOLUMAB OFATUMUMAB OLAPARIB OSIMERTINIB PALBOCICLIB PANITUMUMAB PANOBINOSTAT PAZOPANIB PEMBROLIZUMAB PERTUZUMAB PIRTOBRUTINIB PONATINIB PRALSETINIB REGORAFENIB RELATLIMAB REPOTRECTINIB RIBOCICLIB RIPRETINIB ROMIDEPSIN RUXOLITINIB SACITUZUMAB GOVITECAN HZIY SELPERCATINIB SORAFENIB SUNITINIB TALAZOPARIB TEBENTAFUSP-TEBN TECLISTAMAB-CQYV TEPOTINIB TISOTUMAB TORIPALIMAB-TPZI TRAMETINIB TRASTUZUMAB TREMELIMUMAB-ACTL TUCATINIB VEMURAFENIB
